HCA UK hospital awarded ‘gold standard’ in myeloma care
Outstanding care and treatment of complex, incurable blood cancer recognised by national charity.
HCA Healthcare UK at University College Hospital (HCA UK at UCH) has been awarded the gold standard in myeloma care by the charity Myeloma UK.
Myeloma UK’s Clinical Service Excellence Programme has been designed by patients and healthcare professionals to raise the benchmark in treatment and care of this complex disease.
Clinical Nurse Specialists and supportive therapists are integral to the design of the service, which centres on the emotional and physical impact of a myeloma diagnosis on the patient, whilst providing the most advanced treatment based on latest research and guidelines.
As one of the only private hospitals in the UK with the expertise required to treat myeloma, the multidisciplinary service at HCA UK at UCH brings together some of the UK’s leading authorities in national myeloma research, including Professor Kwee Lan Yong, Chief Investigator on Phase II studies into the disease.
As a specialist centre for the treatment of cancer and red blood cell disorders, HCA UK at UCH is a joint venture between HCA Healthcare UK and University College London Hospitals. The latest prestigious accreditation follows an Outstanding rating by the Care Quality Commission, the UK’s independent regulator of healthcare providers, and JACIE accreditation for their bone marrow and stem cell transplant centre.
About myeloma
References
The Leader - Issue One
Discussing advances in medicine - from the UK's healthcare leaders
